Primary Immunodeficiency I

53

Prenatal and postnatal exposure to perfluoroalkyl substances and antibody concentrations with mass vaccination in 5, 8, 11 and 14 year-old children in Taiwan
Shu-Li Julie Wang Shiang-Jen Jane Lin Hui-Ju Wen Yuliang Leon Guo

54

Basophils and IL-4 Dampen the Protective Innate Immune Response Against Cutaneous Staphylococcus aureus Infection.
Raif S. Geha, MD FAAAAI Juan-Manuel Leyva-Castillo, PhD

55

Mast Cell Activation Disorder As A Presentation Of Primary Immunodeficiencies
Anne L. Maitland, MD PhD Sydney Littlejohn Gigia Roizen

56

Immunoglobulin Reference Ranges In An Appalachian Pediatric Population
Apoorwa Thati, MS, BS Ahmad Al Balbissi, MD Sumana Reddy, MD Rodrigo Tejeida-Estrada, BS Kevin F. Breuel, PhD, MS Alexei Gonzalez-Estrada, MD

57

Presentation and Skin Biopsy Findings in Delayed Type Hypersensitivity Reactions to Facilitated Subcutaneous Immunoglobulin Replacement
Kara B McNamara, MD Jim M. Fernandez, MD PhD Lily Pien, MD FAAAAI Dawn M. Zacharias, MD

58

Genetic and Mechanistic Diversity in Hemophagocytic Lymphohistiocytosis
Ivan K Chinn, MD Olive S Eckstein, MD Erin C Peckham-Gregory, PhD Baruch R Goldberg, MD Lisa R. Forbes, MD Sarah K. Nicholas, MD Emily M Mace, PhD Tiphanie P Vogel, MD, PhD Harshal A Abhyankar Maria I Diaz Helen E Heslop, MD Robert A Krance, MD Caridad A Martinez, MD Trung C Nguyen, MD Dalia A Bashir, MD Jordana R Goldman, MD Asbjorg Stray-Pedersen, MD, PhD Luis A Pedroza, PhD M. Cecilia Poli, MD Juan Carlos Aldave Becerra, MD Sean A. McGhee, MD FAAAAI Zeynep H Coban-Akdemir, PhD Shalini N Jhangiani Donna M Muzny Tram N Cao Diana N Hong Richard A Gibbs, PhD James R Lupski, MD, PhD Jordan S Orange, MD PhD FAAAAI Kenneth L McClain, MD PhD Carl E Allen, MD, PhD

59

Screening for immunodeficiency in patients with community-acquired pneumonia
Syed Mustafa, MD FAAAAI Karthik Vadamalai Denise Sanchez Tejera Jonathan Bress

60

Pharmacokinetics of Hizentra at Weekly vs. Biweekly Dosing Regimens
Mikhail Rojavin Hugo Chapdelaine, MD Gautam Baheti Jutta Hofmann Michaela Praus Michael Tortorici Elie Haddad

61

The effects of DOCK8 deficiency on human neutrophil functions
Amarilla B Mandola, MD Jacov Levy, MD Amit Nahum, MD, PhD Nurit Hadad Rachel Levy, PhD Anna Rylova Amos J Simon, PhD Atar Lev, PhD Raz Somech, MD PhD Arnon Broides, MD

62

Serum total Immunoglobulin and Mycoplasma pneumonia
Jung Hyun Kwon, MD., PhD. Won Hee Seo, MD., PhD. Young Yoo, MD PhD Dae Jin Song, MD., PhD. Ji Tae Choung, MD., Phd.

63

Heterozygous Mutations in NFKB2 Exhibit a Broad Clinical Phenotype
Erik N Newman Julie Feusier Shancy P Jacob Lynn B Jorde Harry R Hill Celine Hanson Kazushi Izawa T. Ronan Leahy Masafumi Yamada William Rae Fabian Hauck Hassan Abolhassani Asghar Aghamohammadi Lennart Hammarström Hirokazu Kanegane Charlotte Slade Chaim M Roifman Bodo Grimbacher Guy A Zimmerman John F Bohnsack Karin Chen

64

Incidence of reactivated Herpes Zoster (shingles) in patients with Primary Immune Deficiency
David S Lindsay, MD Charlotte Cunningham-Rundles, MD PhD FAAAAI Ramsay L. Fuleihan, MD FAAAAI Mark Ballow, MD FAAAAI Jennifer W. Leiding, MD FAAAAI

66

Characterization of pediatric onset common variable immunodeficiency (CVID) in a large cohort
Carolyn H. Baloh, MD Anupama Reddy, PhD Rebecca H. Buckley, MD FAAAAI Patricia L. Lugar, MD MS

67

Predictors of persistent respiratory infections in patients with primary antibody deficiency, data from the US Immunodeficiency network (USIDnet)
Joud Hajjar, MD Carleigh Kutac, MS Jordan S Orange, MD PhD FAAAAI

68

Clinical Diagnostic Difficulties of Post-Rituximab Secondary Immunodeficiency Prior to the Onset of Long Term Complications
Jeehyun Katie Rha, MD Elise Loughman, BS Marissa A. Love, MD Selina A. Gierer, DO FAAAAI